| 摘要 |
THE CRYSTALLINE POLYMORPH FORM I OF (-)-4-[4-[4-[4-[[(2R-CIS)-5-(2,4-DIFLUOROPHENYL) TETRAHYDRO-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)FURAN-3-YL] METHOXY]PHENYL]-1-PIPERAZINYL]PHENYL-2,4-DIHYDRO-2- [(S)-1-ETHYL 2(S)-HYDROXYLPROPYL]-3H-1,2,4-TRIAZOL-3-ONE REPRESENTED BY FORMULA (I), PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH A POLYMORPH AND METHODS OF USING SUCH A POLYMORPH TO TREAT FUNGAL INFECTIONS IN MAMMALS ARE DISCLOSED.(FIG 1)
|
